Univar Solutions Inc - UNVR STOCK NEWS

Univar Solutions (NYSE: UNVR) has partnered with Vitamin Angels to enhance maternal and child health by improving access to essential nutrients for underserved populations. The collaboration aims to tackle global malnutrition, particularly among pregnant women and children under five. Univar Solutions leverages over 50 years of experience in the nutraceuticals sector to support Vitamin Angels, which serves 60 million women and children in the U.S. and 65 countries. This initiative aligns with Univar's mission of fostering healthier communities through nutrition.

Univar Solutions (NYSE: UNVR) has expanded its partnership with Novozymes, a leader in biological solutions, to enhance distribution in Latin America. The agreement focuses on distributing enzymes for dairy and protein sectors in Brazil, Colombia, Ecuador, Peru, and Bolivia, while in Mexico and Central America, the entire food and beverage enzyme portfolio will be distributed. This strategic move is expected to leverage growth opportunities and strengthen Univar's offerings in the food ingredients sector.

Univar Solutions (NYSE: UNVR) will report its Q1 2021 financial results on May 7, 2021, after market close. A news release will be available alongside a slide presentation on the investor relations website. An investor webcast is scheduled for May 10, 2021, at 9:00 a.m. ET to discuss the results. The company operates as a global chemical distributor and is committed to delivering value-added services to customers.

Univar Solutions Inc. announces the expansion of its distribution agreement with Niacet Corporation to include the sales and marketing of Niaproof Anionic Surfactant 08 in Mexico. This product, certified under CleanGredients® for environmentally friendly products, boasts over 80% biodegradability and enhances wetting and emulsifying. The agreement builds on a relationship that began in 2009 across multiple regions, including the US, Europe, and Africa. Executives from both companies express optimism about future growth opportunities through this enhanced partnership.

Univar Solutions (NYSE: UNVR) and Novozymes have expanded their partnership to the U.S. and Canadian markets, effective April 1, 2021. This agreement aims to bring innovative and sustainable biological solutions to homecare, industrial cleaning, and beverage sectors. The collaboration emphasizes leveraging Novozymes' enzyme and microbial technologies to enhance sustainability and product performance. With over 15 years of successful partnership in Europe, the extension is expected to enhance customer experience through improved digital strategies and operational efficiency.

Univar Solutions (NYSE: UNVR) and Novozymes announced an expanded partnership, effective April 1, to serve the U.S. and Canadian markets for homecare, industrial cleaning, and beverages. This collaboration focuses on utilizing sustainable biological solutions, enhancing product performance, and improving customer experience through digital strategies. The agreement builds on their successful 15-year relationship in Europe, aiming to leverage innovations in enzyme and microbial technologies. Together, they strive to meet sustainability goals and capitalize on consumer demand for eco-friendly products.

Univar Solutions Inc. (NYSE: UNVR) announced an expanded agreement with Sensient Technologies to distribute synthetic coloring products in Mexico for food, beverage, nutraceutical, and pharmaceutical markets. This builds on existing partnerships in Canada and Europe. The agreement enhances Univar's capabilities, allowing it to provide tailored solutions to meet customer needs and support innovative product development. Sensient aims to leverage this partnership to offer best-in-class color solutions, promoting competitive advantages for manufacturers.

Univar Solutions reported Q4 2020 financial results, showing net income of $(33.7) million, improving from $(55.1) million year-over-year. Adjusted net income was $45.2 million, down from $50.5 million. Revenue decreased 5.5% to $2.0 billion due to divestitures and lower industrial demand. Adjusted EBITDA fell 7.8% to $146.4 million, with an EBITDA margin of 7.2%. The full year saw net income rise to $52.9 million from a loss of $(100.2) million in 2019. The company anticipates 2021 Adjusted EBITDA between $630 million and $650 million, reflecting ongoing market conditions.